🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is for adult men with previously untreated high risk, very high ...
Status
Recruiting
Location
Medical University of South Carolina Hollings Cancer Center
Start Date
2026-02-02
Trial ID
NCT07325721
Treatments Being Tested
Purpose: Prospective, single-site Phase II study testing whether PSMA-PET/M...
Status
Recruiting
Location
University of Nebraska Medical Center
Start Date
2026-03-31
Trial ID
NCT07234981
Treatments Being Tested
This is a multi-center, multi-arm open-label phase Ib/II clinical study ass...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-31
Trial ID
NCT06217536
Treatments Being Tested
Data of survival benefit from adjuvant chemotherapy (ACT) after concurrent ...
Status
Unknown
Location
Bhumibol Adulyadej Hospital
Start Date
2014-01
Trial ID
NCT02036164
Treatments Being Tested
Stereotactic body radiotherapy (SBRT) has emerged as an effective and safe ...
Status
Unknown
Location
China, SiChuan
Start Date
2022-06-30
Trial ID
NCT05430737
Treatments Being Tested
* INTERACT study: to evaluate the pathological response rate in cT3 rectal ...
Status
Unknown
Location
Catholic University of Sacred Heart
Start Date
2005-10
Trial ID
NCT01653301
The goal of this clinical trial is to evaluate a strategy integrating adjuv...
Status
Recruiting
Location
Centre Hospitalier Emile Roux
Start Date
2025-02-21
Trial ID
NCT06692556
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays and other types of rad...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-09
Trial ID
NCT00936390
Treatments Being Tested
The study objective: * To evaluate the response and survival rates after t...
Status
Completed
Location
Chittaranjan National Cancer Institute
Start Date
2007-10
Trial ID
NCT01276730
Treatments Being Tested
A Phase II Study of Serplulimab Plus Chemoradiotherapy as Adjuvant Treatmen...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2024-11-19
Trial ID
NCT06727617
Treatments Being Tested